Next Generation Sequencing Market Research Report: By Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome Sequencing), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), Application (Oncology, Clinical Investigation, Reproductive Health, Human Leukocyte Antigen Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), End User (Hospitals & Clinics, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Global Forecast till 2025
Global Next Generation Sequencing Market Share is expected to exhibit significant growth over the forecast period. The NGS Market Growth is projected to register a CAGR of 18.05% over the forecast period to reach USD 20,347.45 Million by 2025.
There are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease etc. To discover viable treatment to these diseases, researchers are looking to discern how genes work. Next generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to field of genomics. The NGS technologies are implemented for several applications, including whole genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level. The successful application of next-generation sequencing can lead to predicting of genes, protein coding regions, and pathways.
Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next generation sequencing market which is estimated to reach a massive market valuation by 2023.
Next Generation Sequencing Market Competitive Landscape:
Some of the key players in the global next-generation sequencing market Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI, PerkinElmer, Agilent Technologies, QIAGEN N. V., Macrogen Inc., Oxford Nanopore Technologies, Ltd., and Eurofins Scientific.
Next Generation Sequencing Market Segmentation:
The next generation sequencing market has been classified by technology, service and product, application, and end-user.
By technology, next generation sequencing market has been segmented as whole genome sequencing, methyl sequencing, whole exome sequencing, targeted resequencing, CHIP sequencing, RNA sequencing and de novo sequencing.
By service & product, next generation sequencing market has been segmented as consumables, sample preparation, sequencing services and platforms and services for platforms.
By application, NGS market has been segmented as genetic screening, drug discovery, diagnostics, agriculture and animal research and others.
End-users segmentation of the next generation sequencing market includes academic institutes and research centers, pharmaceutical and biotechnology companies, hospitals and clinics, and other end-users.
Browse More Information @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354
Next Generation Sequencing Market Regional Analysis
Owing to rising number of funds being granted for research into genomics and initiatives adopted by the government to rein in cases of genetically occurring diseases and demand to improve the healthcare sector is estimated to augment the growth of the next generation sequencing market in North America. Increased competition among market players as well as acquisitions and mergers are expected to drive the growth of the market in the region.
Next generation sequencing market in Europe is expected to hold the second largest revenue share due to the presence of some of the leading next-generation sequencing technology companies and an educated population inclined on the advancement of next-generation sequencing technology. Though diverse regulations and a fragmented NGS market might restrain the growth of the market in the region, favorable funding scenario and immense support for scientific research would augment next-generation sequencing market in the region.
The next-generation sequencing market share in Asia-Pacific is projected to witness expansion over the coming years due to growing demand for advanced technology and access to enhanced treatment facilities, better adoption of advanced genomics, increase in disposable income, and rising investments in diverse treatment options by pharmaceutical companies.
Due to lack of technical knowledge, an underdeveloped healthcare sector, and poor medical facilities the next generation sequencing market in the Middle East and Africa is expected to garner the smallest share.
New York, NY 13 May 2021: The global next generation sequencing market expected to reach US$ 25.85 billion by 2028 according to a new study by Polaris Market Research.
The report “Next Generation Sequencing (NGS) Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases, Agricultural & Animal Research); By Technology; By Product; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Market players are focusing on developing automated sequencers equipped with high speed and accuracy.
This has also enabled increased adoption in emerging nations.
In terms of application, the market is segmented into drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample Segment HighlightsInfectious diseases segment is estimated to hold a major share in the global next generation sequencing market, owing to increasing usage of NGS in infectious diseases.
The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025.
It has helped in various applied fields which includes biotechnology, forensic research, virology and medical diagnosis.
High capacity genome sequencing has been contributing significantly towards the market growth.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/next-generation-sequencing-ngs-market/request-sampleNGS has wide applications in the field of exome and genome sequencing.
This technology has also helped the pharmaceutical companies in developing essential drugs for the treatment of cancer and infectious diseases.
Growing concerns and increasing incidences of cancer is expected to be the major driving factor for the development of NGS.NGS in the field of organ transplant provides great opportunities over the forecast period.
NGS helps in studying the immune response to the transplanted organ.
NGS means next-generation sequencing it is also known as massively parallel sequencing technology.
NGS allows researchers to research on various applications including speed, scalability, and ultra-high throughput and also study biological systems at a next level.
NGS allows researchers to rapidly sequence whole genomes.
Global next generation sequencing (NGS) market is registering a healthy CAGR of 19.60 % in the forecast period of 2019-2026.
This rise in the market can be attributed to the continuous advancement in NGS technology and upsurge in applications of NGS.
Get a Sample Copy of Global Next Generation Sequencing Market Report to Understand the Complete Insights @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-marketMarket Drivers and Restraints:Continuous technological advancement in NGS platform is driving the market growthReducing price of NGS installation is another factor helping in market growthProper reimbursement and improving regulatory scenario are flourishing the market growthUpsurge in applications of next generation sequencing drives the growth of the marketLess number of skilled personnel hinders the market growthRising concern about standardization of NGS based diagnostics hampers the market growthLegal and ethical restrictions will act as market restraintsThe major players covered in the Next Generation Sequencing MarketFew of the major market competitors currently working in the global next generation sequencing (NGS) market are Illumina, Inc., BGI, Eurofins Scientific, PerkinElmer Inc., Macrogen Inc., DNA Link, Inc., Genotypic Technology Pvt Ltd, WuXi AppTec, GENEWIZ, Takara Bio Inc., SciGenom Labs Pvt.
